Australia markets close in 5 hours 59 minutes
  • ALL ORDS

    7,577.20
    +18.40 (+0.24%)
     
  • ASX 200

    7,312.30
    +9.80 (+0.13%)
     
  • AUD/USD

    0.7713
    -0.0001 (-0.01%)
     
  • OIL

    71.17
    +0.29 (+0.41%)
     
  • GOLD

    1,867.90
    +2.00 (+0.11%)
     
  • BTC-AUD

    52,363.04
    +1,726.64 (+3.41%)
     
  • CMC Crypto 200

    1,008.60
    +39.76 (+4.10%)
     
  • AUD/EUR

    0.6362
    +0.0001 (+0.01%)
     
  • AUD/NZD

    1.0793
    -0.0002 (-0.02%)
     
  • NZX 50

    12,581.54
    +19.37 (+0.15%)
     
  • NASDAQ

    14,128.20
    +129.90 (+0.93%)
     
  • FTSE

    7,146.68
    +12.62 (+0.18%)
     
  • Dow Jones

    34,393.75
    -85.85 (-0.25%)
     
  • DAX

    15,673.64
    -19.63 (-0.13%)
     
  • Hang Seng

    28,842.13
    +103.23 (+0.36%)
     
  • NIKKEI 225

    29,161.80
    0.00 (0.00%)
     

Global Neglected Tropical Diseases Diagnosis Market Research Report 2021 - ResearchAndMarkets.com

·2-min read

DUBLIN, Jun 11, 2021--(BUSINESS WIRE)--The "Neglected Tropical Diseases Diagnosis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at a CAGR of 4% over the period 2020-2027.

Conventional, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$4.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular / Modern segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.4% CAGR

The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 33 Featured):

  • Abbott Laboratories

  • Beckman Coulter/Danaher

  • Bio-Rad Laboratories, Inc.

  • Coris Bioconcept SPRL

  • DiaSys Diagnostic Systems GmbH

  • F. Hoffmann-La Roche Ltd.

  • Genome Diagnostics Pvt. Ltd

  • InBios International, Inc.

  • Life Technology

  • Novartis Diagnostics., Ltd.

  • Omega Diagnostics Group PLC

  • Ortho-Clinical Diagnostics

  • Oscar Medicare Pvt Ltd.

  • Premier Medical Corporation Ltd.

  • Siemens Healthcare

  • Thermo Fisher Scientific, Inc.

  • Wako Chemicals, Inc.

  • ZeptoMetrix

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UNITED KINGDOM

  • SPAIN

  • RUSSIA

  • REST OF EUROPE

  • ASIA-PACIFIC

  • AUSTRALIA

  • INDIA

  • SOUTH KOREA

  • REST OF ASIA-PACIFIC

  • LATIN AMERICA

  • ARGENTINA

  • BRAZIL

  • MEXICO

  • REST OF LATIN AMERICA

  • MIDDLE EAST

  • IRAN

  • ISRAEL

  • SAUDI ARABIA

  • UNITED ARAB EMIRATES

  • REST OF MIDDLE EAST

  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 33

For more information about this report visit https://www.researchandmarkets.com/r/ngfadu

View source version on businesswire.com: https://www.businesswire.com/news/home/20210611005269/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900